Trinity Biotech Announces Filing of 2014 Annual Report
March 25, 2015 12:21 ET
|
Trinity Biotech plc
DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
Trinity Biotech Announces Results for Q4 and Fiscal Year 2014
March 03, 2015 08:47 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results
February 25, 2015 10:44 ET
|
Trinity Biotech plc
DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product
February 23, 2015 10:18 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test
December 16, 2014 11:26 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Quarter 3 Financial Results and Temporary Suspension of Meritas Troponin Trials
October 23, 2014 09:01 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Third Quarter Fiscal 2014 Financial Results
October 06, 2014 05:45 ET
|
Trinity Biotech plc
DUBLIN, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces CE Marking of New Meritas Heart Failure (BNP) Point-of-Care Test
September 25, 2014 06:24 ET
|
Trinity Biotech plc
DUBLIN, Sept. 25, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
Trinity Biotech Announces Quarter 2 Financial Results; 25% Increase in Operating Profits
July 29, 2014 07:57 ET
|
Trinity Biotech plc
DUBLIN, July 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2014 Financial Results
July 21, 2014 05:31 ET
|
Trinity Biotech plc
DUBLIN, July 21, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...